Author Correction: Neutrophil-to-lymphocyte ratio is a prognostic factor reflecting immune condition of tumor microenvironment in squamous cell lung cancer.
Saved in:
| Title: | Author Correction: Neutrophil-to-lymphocyte ratio is a prognostic factor reflecting immune condition of tumor microenvironment in squamous cell lung cancer. |
|---|---|
| Authors: | Ohashi K; Department of Immune Medicine, National Cancer Center Research Institute, Tsukiji 5-1-1, Chuo-ku, Tokyo, 104-0045, Japan. kaoohash@ncc.go.jp.; Department of Respirology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba, 260-8677, Japan. kaoohash@ncc.go.jp., Nishito Y; Kamakura Research Laboratories, Chugai Pharmaceutical Co., Ltd, 200 Kajiwara, Kamakura, Kanagawa, 247-8530, Japan., Fukuda H; Department of Immune Medicine, National Cancer Center Research Institute, Tsukiji 5-1-1, Chuo-ku, Tokyo, 104-0045, Japan., Sadahiro R; Department of Immune Medicine, National Cancer Center Research Institute, Tsukiji 5-1-1, Chuo-ku, Tokyo, 104-0045, Japan., Yoshida Y; Department of Thoracic Surgery, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo, 104-0045, Japan., Watanabe SI; Department of Thoracic Surgery, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo, 104-0045, Japan., Motoi N; Department of Diagnostic Pathology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo, 104-0045, Japan., Sonobe Y; Kamakura Research Laboratories, Chugai Pharmaceutical Co., Ltd, 200 Kajiwara, Kamakura, Kanagawa, 247-8530, Japan., Mizuno H; Kamakura Research Laboratories, Chugai Pharmaceutical Co., Ltd, 200 Kajiwara, Kamakura, Kanagawa, 247-8530, Japan., Tsunoda H; Kamakura Research Laboratories, Chugai Pharmaceutical Co., Ltd, 200 Kajiwara, Kamakura, Kanagawa, 247-8530, Japan., Tatsumi K; Department of Respirology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba, 260-8677, Japan., Suzuki T; Department of Respirology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba, 260-8677, Japan., Ochiai A; Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwanoha 6-5-1, Kashiwa, Chiba, 277-8577, Japan., Aoki K; Department of Immune Medicine, National Cancer Center Research Institute, Tsukiji 5-1-1, Chuo-ku, Tokyo, 104-0045, Japan. |
| Source: | Scientific reports [Sci Rep] 2024 Dec 13; Vol. 14 (1), pp. 30457. Date of Electronic Publication: 2024 Dec 13. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39672904 AccessLevel: 2 PubTypeId: unknown PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Author Correction: Neutrophil-to-lymphocyte ratio is a prognostic factor reflecting immune condition of tumor microenvironment in squamous cell lung cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ohashi+K%22">Ohashi K</searchLink>; Department of Immune Medicine, National Cancer Center Research Institute, Tsukiji 5-1-1, Chuo-ku, Tokyo, 104-0045, Japan. kaoohash@ncc.go.jp.; Department of Respirology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba, 260-8677, Japan. kaoohash@ncc.go.jp.<br /><searchLink fieldCode="AU" term="%22Nishito+Y%22">Nishito Y</searchLink>; Kamakura Research Laboratories, Chugai Pharmaceutical Co., Ltd, 200 Kajiwara, Kamakura, Kanagawa, 247-8530, Japan.<br /><searchLink fieldCode="AU" term="%22Fukuda+H%22">Fukuda H</searchLink>; Department of Immune Medicine, National Cancer Center Research Institute, Tsukiji 5-1-1, Chuo-ku, Tokyo, 104-0045, Japan.<br /><searchLink fieldCode="AU" term="%22Sadahiro+R%22">Sadahiro R</searchLink>; Department of Immune Medicine, National Cancer Center Research Institute, Tsukiji 5-1-1, Chuo-ku, Tokyo, 104-0045, Japan.<br /><searchLink fieldCode="AU" term="%22Yoshida+Y%22">Yoshida Y</searchLink>; Department of Thoracic Surgery, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo, 104-0045, Japan.<br /><searchLink fieldCode="AU" term="%22Watanabe+SI%22">Watanabe SI</searchLink>; Department of Thoracic Surgery, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo, 104-0045, Japan.<br /><searchLink fieldCode="AU" term="%22Motoi+N%22">Motoi N</searchLink>; Department of Diagnostic Pathology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo, 104-0045, Japan.<br /><searchLink fieldCode="AU" term="%22Sonobe+Y%22">Sonobe Y</searchLink>; Kamakura Research Laboratories, Chugai Pharmaceutical Co., Ltd, 200 Kajiwara, Kamakura, Kanagawa, 247-8530, Japan.<br /><searchLink fieldCode="AU" term="%22Mizuno+H%22">Mizuno H</searchLink>; Kamakura Research Laboratories, Chugai Pharmaceutical Co., Ltd, 200 Kajiwara, Kamakura, Kanagawa, 247-8530, Japan.<br /><searchLink fieldCode="AU" term="%22Tsunoda+H%22">Tsunoda H</searchLink>; Kamakura Research Laboratories, Chugai Pharmaceutical Co., Ltd, 200 Kajiwara, Kamakura, Kanagawa, 247-8530, Japan.<br /><searchLink fieldCode="AU" term="%22Tatsumi+K%22">Tatsumi K</searchLink>; Department of Respirology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba, 260-8677, Japan.<br /><searchLink fieldCode="AU" term="%22Suzuki+T%22">Suzuki T</searchLink>; Department of Respirology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba, 260-8677, Japan.<br /><searchLink fieldCode="AU" term="%22Ochiai+A%22">Ochiai A</searchLink>; Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwanoha 6-5-1, Kashiwa, Chiba, 277-8577, Japan.<br /><searchLink fieldCode="AU" term="%22Aoki+K%22">Aoki K</searchLink>; Department of Immune Medicine, National Cancer Center Research Institute, Tsukiji 5-1-1, Chuo-ku, Tokyo, 104-0045, Japan. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101563288%22">Scientific reports</searchLink> [Sci Rep] 2024 Dec 13; Vol. 14 (1), pp. 30457. <i>Date of Electronic Publication: </i>2024 Dec 13. – Name: TypePub Label: Publication Type Group: TypPub Data: Published Erratum – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101563288 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2045-2322 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220452322%22">20452322 </searchLink><i>NLM ISO Abbreviation: </i>Sci Rep <i>Subsets: </i>MEDLINE; PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39672904 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41598-024-81463-2 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 30457 Titles: – TitleFull: Author Correction: Neutrophil-to-lymphocyte ratio is a prognostic factor reflecting immune condition of tumor microenvironment in squamous cell lung cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ohashi K – PersonEntity: Name: NameFull: Nishito Y – PersonEntity: Name: NameFull: Fukuda H – PersonEntity: Name: NameFull: Sadahiro R – PersonEntity: Name: NameFull: Yoshida Y – PersonEntity: Name: NameFull: Watanabe SI – PersonEntity: Name: NameFull: Motoi N – PersonEntity: Name: NameFull: Sonobe Y – PersonEntity: Name: NameFull: Mizuno H – PersonEntity: Name: NameFull: Tsunoda H – PersonEntity: Name: NameFull: Tatsumi K – PersonEntity: Name: NameFull: Suzuki T – PersonEntity: Name: NameFull: Ochiai A – PersonEntity: Name: NameFull: Aoki K IsPartOfRelationships: – BibEntity: Dates: – D: 13 M: 12 Text: 2024 Dec 13 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2045-2322 Numbering: – Type: volume Value: 14 – Type: issue Value: 1 Titles: – TitleFull: Scientific reports Type: main |
| ResultId | 1 |